The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms
Open accessAbstract
Metabolism of xenobiotics remains a central challenge for the discovery and development of drugs, cosmetics, nutritional supplements, and agrochemicals. Metabolic transformations are frequently related to the incidence of toxic effects that may result from the emergence of reactive species, the systemic accumulation of metabolites, or by induction of metabolic pathways. Experimental investigation of the metabolism of small organic molecules is particularly resource demanding; hence, computational methods are of considerable interest to complement experimental approaches. This review provides a broad overview of structure- and ligand-based computational methods for the prediction of xenobiotic metabolism. Current computational approaches to address xenobiotic metabolism are discussed from three major perspectives: (i) prediction of sites of metabolism (SOMs), (ii) elucidation of potential metabolites and their chemical structures, and (iii) prediction of direct and indirect effects of xenobiotics on metabolizing enzymes, where the focus is on the cytochrome P450 (CYP) superfamily of enzymes, the cardinal xenobiotics metabolizing enzymes. For each of these domains, a variety of approaches and their applications are systematically reviewed, including expert systems, data mining approaches, quantitative structure-activity relationships (QSARs), and machine learning-based methods, pharmacophore-based algorithms, shape-focused techniques, molecular interaction fields (MIFs), reactivity-focused techniques, protein-ligand docking, molecular dynamics (MD) simulations, and combinations of methods. Predictive metabolism is a developing area, and there is still enormous potential for improvement. However, it is clear that the combination of rapidly increasing amounts of available ligand- and structure-related experimental data (in particular, quantitative data) with novel and diverse simulation and modeling approaches is accelerating the development of effective tools for prediction of in vivo metabolism, which is reflected by the diverse and comprehensive data sources and methods for metabolism prediction reviewed here. This review attempts to survey the range and scope of computational methods applied to metabolism prediction and also to compare and contrast their applicability and performance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Dewar, M. J. S., Zoebisch, E. G., Healy, E. F., & Stewart, J. J. P. (1985) · Journal of the American Chemical Society · doi:10.1021/ja00299a024 · Cited by 13,074
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535
CHARMM: The biomolecular simulation program
Brooks, B. R., Brooks, C. L., Mackerell, A. D., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., et al. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21287 · Cited by 8,939
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Improved side‐chain torsion potentials for the Amber ff99SB protein force field
Lindorff‐Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J. L., Dror, R. O., & Shaw, D. E. (2010) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22711 · Cited by 6,134
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W. S., Cheatham, T. E., DeBolt, S., Ferguson, D., Seibel, G., & Kollman, P. (1995) · Computer Physics Communications · doi:10.1016/0010-4655(95)00041-d · Cited by 3,124
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,827
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
6‐31G* basis set for third‐row atoms
Rassolov, V. A., Ratner, M. A., Pople, J. A., Redfern, P. C., & Curtiss, L. A. (2001) · Journal of Computational Chemistry · doi:10.1002/jcc.1058 · Cited by 2,336
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Abagyan, R., Totrov, M., & Kuznetsov, D. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150503 · Cited by 1,699
Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007996124545 · Cited by 1,686
The Many Roles of Computation in Drug Discovery
Jorgensen, W. L. (2004) · Science · doi:10.1126/science.1096361 · Cited by 1,554
Molecular dynamics simulations and drug discovery
Durrant, J. D., & McCammon, J. A. (2011) · BMC Biology · doi:10.1186/1741-7007-9-71 · Cited by 1,403
Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics
Rittle, J., & Green, M. T. (2010) · Science · doi:10.1126/science.1193478 · Cited by 1,368
Automated docking of substrates to proteins by simulated annealing
Goodsell, D. S., & Olson, A. J. (1990) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340080302 · Cited by 1,285
Lessons from 60 years of pharmaceutical innovation
Munos, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2961 · Cited by 1,207
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
Ewing, T. J. A., Makino, S., Skillman, A. G., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011115820450 · Cited by 1,187
P450 Enzymes: Their Structure, Reactivity, and Selectivity—Modeled by QM/MM Calculations
Shaik, S., Cohen, S., Wang, Y., Chen, H., Kumar, D., & Thiel, W. (2010) · Chemical Reviews · doi:10.1021/cr900121s · Cited by 1,083
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Williams, P. A., Cosme, J., Ward, A., Angove, H. C., Matak Vinković, D., & Jhoti, H. (2003) · Nature · doi:10.1038/nature01862 · Cited by 821
Structural basis for ligand promiscuity in cytochrome P450 3A4
Ekroos, M., & Sjögren, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603236103 · Cited by 758
Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
Zhou, S.-F. (2008) · Current Drug Metabolism · doi:10.2174/138920008784220664 · Cited by 719
Sandberg, M., Eriksson, L., Jonsson, J., Sjöström, M., & Wold, S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9700575 · Cited by 678
Molecular similarity: a key technique in molecular informatics
Bender, A., & Glen, R. C. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409813g · Cited by 614
Self-citationComputations of Standard Binding Free Energies with Molecular Dynamics Simulations
Deng, Y., & Roux, B. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp807701h · Cited by 591
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
CAVER: a new tool to explore routes from protein clefts, pockets and cavities
Petřek, M., Otyepka, M., Banáš, P., Košinová, P., Koča, J., & Damborský, J. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-316 · Cited by 521
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist
Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T., & Vianello, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050529c · Cited by 496
Pastor, M., Cruciani, G., McLay, I., Pickett, S., & Clementi, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000941m · Cited by 467
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
Cruciani, G., Pastor, M., & Guba, W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00162-7 · Cited by 419
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
Gillman, P. K. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei210 · Cited by 397
Ligand Binding Affinities from MD Simulations
Åqvist, J., Luzhkov, V. B., & Brandsdal, B. O. (2002) · Accounts of Chemical Research · doi:10.1021/ar010014p · Cited by 380
Baroni, M., Costantino, G., Cruciani, G., Riganelli, D., Valigi, R., & Clementi, S. (1993) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19930120103 · Cited by 375
In silico pharmacology for drug discovery: applications to targets and beyond
Ekins, S., Mestres, J., & Testa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707306 · Cited by 365
The ins and outs of cytochrome P450s
Cojocaru, V., Winn, P. J., & Wade, R. C. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.005 · Cited by 363
The University of Minnesota Biocatalysis/Biodegradation Database: improving public access
Gao, J., Ellis, L. B. M., & Wackett, L. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp771 · Cited by 347
Marchant, C. A., Briggs, K. A., & Long, A. (2008) · Toxicology Mechanisms and Methods · doi:10.1080/15376510701857320 · Cited by 341
SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism
Rydberg, P., Gloriam, D. E., Zaretzki, J., Breneman, C., & Olsen, L. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100016x · Cited by 327
Lüdemann, S. K., Lounnas, V., & Wade, R. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4154 · Cited by 326
Shahrokh, K., Orendt, A., Yost, G. S., & Cheatham, T. E. (2012) · Journal of Computational Chemistry · doi:10.1002/jcc.21922 · Cited by 315
Schöneboom, J. C., Lin, H., Reuter, N., Thiel, W., Cohen, S., Ogliaro, F., & Shaik, S. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026279w · Cited by 309
Westenbrink, H. G. K. (1953) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(53)90292-3 · Cited by 296
Bender, A., Jenkins, J. L., Scheiber, J., Sukuru, S. C. K., Glick, M., & Davies, J. W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800249s · Cited by 294
Self-citationSchöneboom, J. C., Cohen, S., Lin, H., Shaik, S., & Thiel, W. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039847w · Cited by 282
Predicting Drug–Drug Interactions: An FDA Perspective
Zhang, L., Zhang, Y., Zhao, P., & Huang, S.-M. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9106-3 · Cited by 267
Prediction of Drug Binding Affinities by Comparative Binding Energy Analysis
Ortiz, A. R., Pisabarro, M. T., Gago, F., & Wade, R. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00014a020 · Cited by 266
Schöneboom, J. C., Neese, F., & Thiel, W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0424732 · Cited by 260
Mechanisms of cytochrome P450 induction
Tompkins, L. M., & Wallace, A. D. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20180 · Cited by 251
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments
Mukherjee, S., Balius, T. E., & Rizzo, R. C. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1001982 · Cited by 237
The Directive of the Protein: How Does Cytochrome P450 Select the Mechanism of Dopamine Formation?
Schyman, P., Lai, W., Chen, H., Wang, Y., & Shaik, S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201665x · Cited by 234
MOLE: A Voronoi Diagram-Based Explorer of Molecular Channels, Pores, and Tunnels
Petřek, M., Košinová, P., Koča, J., & Otyepka, M. (2007) · Structure · doi:10.1016/j.str.2007.10.007 · Cited by 229
Free Energy Calculations and Ligand Binding
Brandsdal, B. O., Österberg, F., Almlöf, M., Feierberg, I., Luzhkov, V. B., & Åqvist, J. (2003) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(03)66004-3 · Cited by 223
Cytochrome P450 in Silico: An Integrative Modeling Approach
de Graaf, C., Vermeulen, N. P. E., & Feenstra, K. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040180d · Cited by 201
Ekins, S., de Groot, M. J., & Jones, J. P. (2001) · PubMed · Cited by 201
Does Compound I Vary Significantly between Isoforms of Cytochrome P450?
Lonsdale, R., Oláh, J., Mulholland, A. J., & Harvey, J. N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203157u · Cited by 198
Classical force field parameters for the heme prosthetic group of cytochrome c
Autenrieth, F., Tajkhorshid, E., Baudry, J., & Luthey‐Schulten, Z. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20079 · Cited by 196
Kirchmair, J., Distinto, S., Markt, P., Schuster, D., Spitzer, G. M., Liedl, K. R., & Wolber, G. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8004226 · Cited by 193
Self-citationSyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites
Ridder, L., & Wagener, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700312 · Cited by 181
Hewitt, N. J., Lecluyse, E. L., & Ferguson, S. S. (2007) · Xenobiotica · doi:10.1080/00498250701534893 · Cited by 178
Electronic Structure of Compound I in Human Isoforms of Cytochrome P450 from QM/MM Modeling
Bathelt, C. M., Zurek, J., Mulholland, A. J., & Harvey, J. N. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0520924 · Cited by 178
Warr, W. A. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9260-9 · Cited by 176
Ogliaro, F., Cohen, S., de Visser, S. P., & Shaik, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja005619f · Cited by 169
META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals
Klopman, G., Dimayuga, M., & Talafous, J. (1994) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00022a014 · Cited by 169
Deng, Y., & Roux, B. (2008) · The Journal of Chemical Physics · doi:10.1063/1.2842080 · Cited by 164
Structure‐based Drug Metabolism Predictions for Drug Design
Sun, H., & Scott, D. O. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00899.x · Cited by 162
Chu, V., Einolf, H. J., Evers, R., Kumar, G., Moore, D., Ripp, S., Silva, J., Sinha, V., Sinz, M., & Skerjanec, A. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027029 · Cited by 162
Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9
Cojocaru, V., Balali-Mood, K., Sansom, M. S. P., & Wade, R. C. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002152 · Cited by 156
A Pharmacophore for Human Pregnane X Receptor Ligands
Ekins, S., & Erickson, J. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.1.96 · Cited by 155
The SMARTCyp cytochrome P450 metabolism prediction server
Rydberg, P., Gloriam, D. E. I., & Olsen, L. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq584 · Cited by 153
Bisson, W. H., Koch, D. C., O’Donnell, E. F., Khalil, S. M., Kerkvliet, N. I., Tanguay, R. L., Abagyan, R., & Kolluri, S. K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900199u · Cited by 149
Yap, C. W., & Chen, Y. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0500536 · Cited by 148
Lüdemann, S. K., Lounnas, V., & Wade, R. C. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4155 · Cited by 143
Afzelius, L., Arnby, C. H., Broo, A., Carlsson, L., Isaksson, C., Jurva, U., Kjellander, B., Kolmodin, K., Nilsson, K. L., Raubacher, F., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530600969374 · Cited by 141
Predicting Drug Metabolism: A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9
Zamora, I., Afzelius, L., & Cruciani, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021104i · Cited by 138
Mekenyan, O. G., Dimitrov, S. D., Pavlov, T. S., & Veith, G. D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043452596 · Cited by 135
What common structural features and variations of mammalian P450s are known to date?
Otyepka, M., Skopalík, J., Anzenbacherová, E., & Anzenbacher, P. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.09.013 · Cited by 134
Venkatraman, V., Pérez‐Nueno, V. I., Mavridis, L., & Ritchie, D. W. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100263p · Cited by 133
de Graaf, C., Oostenbrink, C., Keizers, P. H. J., van der Wijst, T., Jongejan, A., & Vermeulen, N. P. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508538 · Cited by 131
Stella, V. J., Tilley, J., Oliyai, R., Maag, H., Hageman, M. J., & Borchardt, R. T. (2007) · Springer eBooks · doi:10.1007/978-0-387-49785-3 · Cited by 131
Fishelovitch, D., Shaik, S. S., Wolfson, H. J., & Nussinov, R. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp810386z · Cited by 129
Skopalík, J., Anzenbacher, P., & Otyepka, M. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp800311c · Cited by 128
Identification of a functional water channel in cytochrome P450 enzymes
Oprea, T. I., Hummer, G., & Garcı́a, A. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2133 · Cited by 128
Xue, Y., Chao, E. Y. H., Zuercher, W. J., Willson, T. M., Collins, J. L., & Redinbo, M. R. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.12.026 · Cited by 127
Li, D., Huang, X., Han, K., & Zhan, C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111657j · Cited by 126
Trunzer, M., Faller, B., & Zimmerlin, A. G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8008663 · Cited by 125
Hritz, J., de Ruiter, A., & Oostenbrink, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801005m · Cited by 124
Compound I Reactivity Defines Alkene Oxidation Selectivity in Cytochrome P450cam
Lonsdale, R., Harvey, J. N., & Mulholland, A. J. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp910127j · Cited by 123
Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling?
Schleinkofer, K., sudarko, S., Winn, P. J., Ludemann, S. K., & Wade, R. C. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400420 · Cited by 123
Designing better drugs: predicting cytochrome P450 metabolism
de Groot, M. J. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.001 · Cited by 122
Improved Ligand-Protein Binding Affinity Predictions Using Multiple Binding Modes
Stjernschantz, E., & Oostenbrink, C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.02.034 · Cited by 119
Geometry-Based Sampling of Conformational Transitions in Proteins
Seeliger, D., Haas, J., & de Groot, B. L. (2007) · Structure · doi:10.1016/j.str.2007.09.017 · Cited by 118
WOMBAT: World of Molecular Bioactivity
Olah, M., Mracec, M., Halip, L., Rad-Curpăn, R., Bora, A., Hadaruga, N. G., Olah, I., Banda, M., Simon, Z., Mracec, M., et al. (2005) · Methods and principles in medicinal chemistry · doi:10.1002/3527603743.ch9 · Cited by 117
MolAxis: Efficient and accurate identification of channels in macromolecules
Yaffe, E., Fishelovitch, D., Wolfson, H. J., et al. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22052 · Cited by 115
Pharmacophore modeling of cytochromes P450
de Groot, M. J., & Ekins, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00009-1 · Cited by 112
Emerging Methods for Ensemble-Based Virtual Screening
Amaro, R. E., & Li, W. W. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232279 · Cited by 111
de Graaf, C., Pospíšil, P., Pos, W., Folkers, G., & Vermeulen, N. P. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049650u · Cited by 111
Development of a Combined Protein and Pharmacophore Model for Cytochrome P450 2C9
de Groot, M. J., Alex, A. A., & Jones, B. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110791 · Cited by 109
Oda, A., Yamaotsu, N., & Hirono, S. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20221 · Cited by 107
Classification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning Techniques
Poongavanam, V., Taboureau, O., Oostenbrink, C., Vermeulen, N. P. E., Olsen, L., & Jørgensen, F. S. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023507 · Cited by 105
Kirchmair, J., Markt, P., Distinto, S., Schuster, D., Spitzer, G. M., Liedl, K. R., Langer, T., & Wolber, G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005977 · Cited by 105
Self-citationReaction Site Mapping of Xenobiotic Biotransformations
Boyer, S. K., Arnby, C. H., Carlsson, L., Smith, J., Stein, V., & Glen, R. C. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600376q · Cited by 103
Self-citationAfzelius, L., Zamora, I., Ridderström, M., Andersson, T. B., Karlén, A., & Masimirembwa, C. M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09261-7 · Cited by 98
Zaretzki, J. M., Bergeron, C., Rydberg, P., Huang, T.-W., Bennett, K. P., & Breneman, C. M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2000488 · Cited by 95
Hennemann, M., Friedl, A., Lobell, M., Keldenich, J., Hillisch, A., Clark, T., & Göller, A. H. (2009) · ChemMedChem · doi:10.1002/cmdc.200800384 · Cited by 95
Computational Alchemy To Calculate Absolute Protein−Ligand Binding Free Energy
Helms, V., & Wade, R. C. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9738539 · Cited by 94
The Challenges Involved in Modeling Toxicity Data In Silico: A Review
Gleeson, M. P., Modi, S. P., Bender, A., Robinson, R. M., Kirchmair, J., Promkatkaew, M., Hannongbua, S., & Glen, R. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436359 · Cited by 94
Self-citationLigand-Based Models for the Isoform Specificity of Cytochrome P450 3A4, 2D6, and 2C9 Substrates
Terfloth, L., Bienfait, B., & Gasteiger, J. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700010t · Cited by 93
Ekins, S., Mirny, L. A., & Schuetz, E. G. (2002) · Pharmaceutical Research · doi:10.1023/a:1021429105173 · Cited by 92
Seifert, A., Tatzel, S., Schmid, R. D., & Pleiss, J. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20951 · Cited by 91
Gupta, R. R., Gifford, E., Liston, T., Waller, C. L., Hohman, M. M., Bunin, B. A., & Ekins, S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034918 · Cited by 89
Park, H., Lee, S., & Suh, J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053809q · Cited by 88
Computational prediction of human drug metabolism
Ekins, S., Andreyev, S., Ryabov, A., Kirillov, E., Rakhmatulin, E. A., Bugrim, A. E., & Nikolskaya, T. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.303 · Cited by 87
Favia, A. D., Cavalli, A., Masetti, M., Carotti, A., & Recanatini, M. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20829 · Cited by 86
The Identification of Ligand Features Essential for PXR Activation by Pharmacophore Modeling
Schuster, D., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049722q · Cited by 86
Carlsson, L., Spjuth, O., Adams, S., Glen, R. C., & Boyer, S. K. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-362 · Cited by 85
Self-citationEitrich, T., Kless, A., Druska, C., Meyer, W. E., & Grotendorst, J. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci6002619 · Cited by 85
Machine Learning Techniques for In Silico Modeling of Drug Metabolism
Fox, T., & Kriegl, J. M. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778108915 · Cited by 83
Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands
Poongavanam, V., Hritz, J., Taboureau, O., Olsen, L., Jørgensen, F. S., Vermeulen, N. P. E., & Oostenbrink, C. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800371f · Cited by 81
Yasuda, K., Ranade, A. R., Venkataramanan, R., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020701 · Cited by 81
IDSite: An Accurate Approach to Predict P450-Mediated Drug Metabolism
Li, J., Schneebeli, S. T., Bylund, J. H., Farid, R., & Friesner, R. A. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct200462q · Cited by 79
Incorporating Molecular Shape into the Alignment-free GRid-INdependent Descriptors
Fontaine, F., Pastor, M., & Sanz, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311240 · Cited by 79
In Silico Prediction of Pregnane X Receptor Activators by Machine Learning Approache
Ung, C. Y., Li, H., Yap, C. W., & Chen, Y. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027623 · Cited by 77
Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450
Stjernschantz, E., Vermeulen, N. P. E., & Oostenbrink, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.513 · Cited by 77
Zvinavashe, E., Murk, A. J., & Rietjens, I. M. C. M. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800252e · Cited by 76
Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction
Almond, L. M., Yang, J., Jamei, M., Tucker, G. T., & Rostami‐Hodjegan, A. (2009) · Current Drug Metabolism · doi:10.2174/138920009788498978 · Cited by 76
In silico tools to aid risk assessment of endocrine disrupting chemicals
Jacobs, M. N. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.036 · Cited by 75
Zhou, D., Afzelius, L., Grimm, S. W., Andersson, T. B., Zauhar, R. J., & Zamora, I. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008631 · Cited by 75
Hendrychova, T., Anzenbacherová, E., Hudeček, J., Skopalík, J., Lange, R., Hildebrandt, P., Otyepka, M., & Anzenbacher, P. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.07.017 · Cited by 73
Kirchmair, J., Ristic, S., Eder, K., Markt, P., Wolber, G., Laggner, C., & Langer, T. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700024q · Cited by 73
Self-citationHewitt, N. J., de Kanter, R., & LeCluyse, E. L. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.009 · Cited by 72
Yeung, C. K., Fujioka, Y., Hachad, H., Lévy, R. H., & Isoherranen, N. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.252 · Cited by 72
Role of Water in Molecular Docking Simulations of Cytochrome P450 2D6
Santos, R., Hritz, J., & Oostenbrink, C. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900293e · Cited by 71
Sykes, M. J., McKinnon, R. A., & Miners, J. O. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009793 · Cited by 70
Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data
Sun, H., Veith, H., Xia, M., Austin, C. P., & Huang, R. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200311w · Cited by 65
Lozano, J. J., Pastor, M., Cruciani, G., Gaedt, K., Centeno, N. B., Gago, F., & Sanz, F. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008164621650 · Cited by 65
Fishelovitch, D., Shaik, S. S., Wolfson, H. J., & Nussinov, R. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp101894k · Cited by 61
Kuhn, B., Jacobsen, W., Christians, U., Benet, L. Z., & Kollman, P. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010079y · Cited by 61
Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors
Oprea, T. I., & Garc�a, A. E. (1996) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00355042 · Cited by 60
Lemaire, G., Benod, C. C., Nahoum, V., Pillon, A., Boussioux, A., Guichou, J., Subra, G., Pascussi, J., Bourguet, W., Chavanieu, A., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033415 · Cited by 59
Li, H., Sun, J., Fan, X., Sui, X., Zhang, L., Wang, Y., & He, Z. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9225-4 · Cited by 59
Adaptive Accelerated Molecular Dynamics (Ad-AMD) Revealing the Molecular Plasticity of P450cam
Markwick, P. R. L., Pierce, L., Goodin, D. B., & McCammon, J. A. (2011) · The Journal of Physical Chemistry Letters · doi:10.1021/jz101462n · Cited by 58
Keizers, P. H. J., de Graaf, C., de Kanter, F. J. J., Oostenbrink, C., Feenstra, K. A., Commandeur, J. N. M., & Vermeulen, N. P. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050338+ · Cited by 57
Compound bioactivities go public
Bender, A. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.354 · Cited by 57
Self-citationIn silicosite of metabolism prediction of cytochrome P450-mediated biotransformations
Tarcsay, Á., & Keserű, G. M. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.553599 · Cited by 57
Human CYPs involved in drug metabolism: structures, substrates and binding affinities
Lewis, D. F., & Ito, Y. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003674380 · Cited by 57
Hydration energy landscape of the active site cavity in cytochrome P450cam.
Helms, V., & Wade, R. C. (1998) · PubMed · Cited by 56
Berellini, G., Cruciani, G., & Mannhold, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049024x · Cited by 55
Collins, J., Camper, D. L., & Loew, G. H. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00007a057 · Cited by 51
Serotonin syndrome due to co-administration of linezolid and venlafaxine
Jones, S. L. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh257 · Cited by 51
Hydration energy landscape of the active site cavity in cytochrome P450cam
Helms, V., & Wade, R. C. (1998) · Proteins Structure Function and Bioinformatics · Cited by 51
Metabolexpert: An Expert System for Predicting Metabolism of Substances
Darvas, F. (1987) · Springer eBooks · doi:10.1007/978-94-009-3937-0_7 · Cited by 50
Afzelius, L., Masimirembwa, C. M., Karlén, A., Andersson, T. B., & Zamora, I. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1021281008423 · Cited by 50
Michielan, L., Terfloth, L., Gasteiger, J., et al. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900299a · Cited by 49
Li, W., Liu, H. S., Scott, E. E., Gräter, F., Halpert, J. R., Luo, X., Shen, J., & Jiang, H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004200 · Cited by 49
Li, Q., Bender, A., Pei, J., & Lai, L. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700107y · Cited by 49
Self-citationWu, B., Zhang, Y., Kong, J., Zhang, X., & Cheng, S. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.08.005 · Cited by 46
Korhonen, L. E., Turpeinen, M., Rahnasto, M., Wittekindt, C., Poso, A., Pelkonen, O., Raunio, H., & Juvonen, R. O. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707173 · Cited by 46
Quantitative Structure Activity Relationships in Drug Metabolism
Chohan, K. K., Paine, S. W., & Waters, N. J. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778108960 · Cited by 46
Lampe, J. N., Brandman, R., Sivaramakrishnan, S., & de Montellano, P. R. O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087593 · Cited by 45
Crivori, P., Zamora, I., Speed, B., Orrenius, C., & Poggesi, I. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1023/b:jcam.0000035184.11906.c2 · Cited by 44
Molecular shape and electrostatics in the encoding of relevant chemical information
Nicholls, A. O., & Grant, J. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-9019-x · Cited by 43
Pérez‐Nueno, V. I., & Ritchie, D. W. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100492r · Cited by 42
Classification of Cytochrome P450 Activities Using Machine Learning Methods
Hammann, F., Gutmann, H., Baumann, U., Helma, C., & Drewe, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900217x · Cited by 42
A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors
Poso, A., Gynther, J., & Juvonen, R. O. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008102217770 · Cited by 41
Diet and Monoamine Oxidase Inhibitors: A Re-Examination
Sullivan, E. A., & Shulman, K. I. (1984) · The Canadian Journal of Psychiatry · doi:10.1177/070674378402900814 · Cited by 40
Bazeley, P. S., Prithivi, S., Struble, C. A., Povinelli, R. J., & Sem, D. S. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600267k · Cited by 40
Jyrkkärinne, J., Windshügel, B., Rönkkö, T., Tervo, A. J., Küblbeck, J., Lahtela-Kakkonen, M. K., Sippl, W., Poso, A., & Honkakoski, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800731b · Cited by 39
Vedani, A., Smieško, M., Spreafico, M., Peristera, O., & Dobler, M. (2009) · ALTEX · doi:10.14573/altex.2009.3.167 · Cited by 38
Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors
Kontijevskis, A., Komorowski, J., & Wikberg, J. E. S. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000953 · Cited by 38
Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening
Pérez‐Nueno, V. I., Pettersson, S., Ritchie, D. W., Borrell, J. I., & Teixidó, J. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci800468q · Cited by 38
IN SILICO PREDICTION OF DRUG BINDING TO CYP2D6: IDENTIFICATION OF A NEW METABOLITE OF METOCLOPRAMIDE
Yu, J., Paine, M. J. I., Maréchal, J., Kemp, C. A., Ward, C. J., Brown, S., Sutcliffe, M. J., Roberts, G. C. K., Rankin, E. M., & Wolf, C. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009852 · Cited by 38
Quantitative Binding Models for CYP2C9 Based on Benzbromarone Analogues
Locuson, C. W., Rock, D. A., & Jones, J. P. (2004) · Biochemistry · doi:10.1021/bi049651o · Cited by 37
Mu, F., Ünkefer, C. J., Unkefer, P. J., & Hlavacek, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr177 · Cited by 37
Molecular Similarity and Xenobiotic Metabolism
Adams, S. (2010) · doi:10.17863/cam.16274 · Cited by 36
Analysis of binding modes of ligands to multiple conformations of CYP3A4
Teixeira, V. H., Ribeiro, V., & Martel, P. J. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.008 · Cited by 36
QSAR Modeling of in Vitro Inhibition of Cytochrome P450 3A4*
Mao, B., Gozalbes, R., Barbosa, F., et al. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0600915 · Cited by 36
Potential drug–drug interactions within Veterans Affairs medical centers
Mahmood, M. H., Malone, D. C., Skrepnek, G. H., Abarca, J., Armstrong, E. P., Murphy, J. E., Grizzle, A. J., Ko, Y., & Woosley, R. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060548 · Cited by 35
Strobel, S. M., Szklarz, G. D., He, Y., Foroozesh, M. K., Alworth, W. L., Roberts, E. S., Hollenberg, P. F., & Halpert, J. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34919-5 · Cited by 35
Multiple molecular recognition mechanisms. Cytochrome P450—A case study
Wade, R. C., Motiejunas, D., Schleinkofer, K., sudarko, S., Winn, P. J., Banerjee, A., Kariakin, A., & Jung, C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.07.044 · Cited by 33
Roy, K., & Roy, P. P. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903158940 · Cited by 33
Molecular Oxygen Activation and Proton Transfer Mechanisms in Lanosterol 14α-Demethylase Catalysis
Sen, K., & Hackett, J. C. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp902932p · Cited by 32
Chang, Y., & Loew, G. H. (2000) · Biochemistry · doi:10.1021/bi991966u · Cited by 31
Pérez‐Nueno, V. I., Ritchie, D. W., Borrell, J. I., & Teixidó, J. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800257x · Cited by 31
The challenges of in silico contributions to drug metabolism in lead optimization
Vaz, R. J., Zamora, I., Li, Y., Reiling, S., Shen, J., & Cruciani, G. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.499123 · Cited by 30
Leong, M. K., Chen, Y., Chen, H.-B., & Chen, P.-H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9807-9 · Cited by 29
Roccatano, D., Wong, T. S., Schwaneberg, U., & Zacharias, M. (2006) · Biopolymers · doi:10.1002/bip.20577 · Cited by 29
Haider, S. M., Patel, J. S., Poojari, C., & Neidle, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.069 · Cited by 27
Scott, E. E., Liu, H., He, Y., Li, W., & Halpert, J. R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.035 · Cited by 26
Lotfipour, S., Arnold, M. M., Hogenkamp, D. J., Gee, K. W., Belluzzi, J. D., & Leslie, F. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.007 · Cited by 25
Roccatano, D., Wong, T. S., Schwaneberg, U., & Zacharias, M. (2005) · Biopolymers · doi:10.1002/bip.20290 · Cited by 24
Cited by
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063
Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics
Dunn, W. B., Erban, A., Weber, R. J. M., Creek, D. J., Brown, M., Breitling, R., Hankemeier, T., Goodacre, R., Neumann, S., Kopka, J., et al. (2013) · Metabolomics · doi:10.1007/s11306-012-0434-4 · Cited by 555
A practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546
Predicting drug metabolism: experiment and/or computation?
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4581 · Cited by 502
Self-citation
Metadata
- Authors
- Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-02-17
- Volume
- 52
- Issue
- 3
- Pages
- 617-648
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W2090505208
- Cited by
- 289
- References
- 210
- FWCI
- 36.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.